A Phase 1 study of LOXO-435 in Locally Advanced or Metastatic Solid Tumors with FGFR3 Gene Alterations

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502755-59-00

Acronym

LOXO-FG3-22001

Enrollment

Registered

2023-06-28

Start date

2023-08-30

Completion date

Unknown

Last updated

2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced or Metastatic Solid Tumors with FGFR3 Alterations

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Netherlands, Norway, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026